ROL' POLOVYKh GORMONOV V REGULYaTsII KOSTNOGO OBMENA i mineral'noy plotnostikostnoy tkani u muzhchin v pozdnie sroki posle allotransplantatsii trupnoy pochki
https://doi.org/10.14341/osteo200622-5
Abstract
Lumbal spine and hip bone mineral density (BMD), bone turnover markers [bone alkaline phosphatase (bALP), osteocalcin (OC), aminoterminal procollagen I propeptide, bone acid phosphatase (bACP), ß-crosslaps (CTX)], sex hormones [testosterone, estradiol (E2), sex hormone-binding globulin (SHBG), free androgen index (FAI), free estrogen index (FEI)], parathyroid hormone (PTH), osteoprotegerin (OPG) and insulin-like growth factor-1 (IGF-1)] were determined in 39 men in age 42±10 years (33 with well renal function and 6 - with renal failure (RF) 44±26 months following KT receiving triple immunosuppressive therapy (CysA, prednisolone and azathioprine). Increased CTX, bACP, OC and decreased bALP so as BMD were associated in men following KT with low testosterone, SHBG and IGF-1 and high E2, OPG and PTH. There was more degree of bone turnover disturbances, decreased BMD, PTH hypersecretion and low FAI in RF. There were significant positive relationships between serum testosterone and E2, FEI and FAI, bALP and E2, bALP and FEI, femur BMD and FAI, femur BMD and FEI, OPG and E2, IGF-1 and PTH. There were significant inverse correlations between serum CTX and FAI, CTX and FEI, hip (spine) BMD and SHBG, hip (spine) BMD and PTH so as between PTH and FAI, PTH and FEI. So bone turnover disturbances, hip BMD losses and PTH hypersecretion in men at late time following KT associated with sex hormone deficiency. Predictor of high bone turnover and as vertebral as femur bone losses after KT besides PTH hypersecretion was serum SHBG. Decreased IGF-1 was the reason of bone forming suppression and possibly was following cyclosporine hepatotoxicity. OPG increasing was associated partly with high estradiol and was compensatory to attenuation of bone resorption and bone losses.
References
1. Ермакова И.П., Пронченко И.А., Бузулина В.П., Томилина Н.А., Ведерникова Р.Н., Ермоленко А.Е., Ильницкий В.В., Шумаков В.И. Костный метаболизм и потери костной ткани в отдаленные сроки после аллотрансплантации трупной почки (АТП). Одномоментное исследование // Остеопороз и остеопатии. 2005. № 2. C. 30-33.
2. Ермакова И.П., Пронченко И.А., Бузулина В.П., Томилина Н.А., Колиашвили Т.К., Хубутия М.Ш., Шумаков В.И. Остеопротегерин, инсулинподобный фактор роста-1 и биохимические маркеры обмена кости у больных с остеопатиями после пересадки почки и сердца // Остеопороз и остеопатии. 2004. № 2. C. 2-5.
3. Пронченко И.А., Бузулина В.П., Томилина Н.А., Ведерникова Р.Н., Ермакова И.П. Биохимические маркеры костного метаболизма и потерь костной ткани после аллотрансплантации трупной почки. Одномоментное исследование // Клин. лаб. Диагностика. 2005. № 11. С. 3-8.
4. Brandenburg V.M., Ketteler M., Heussen N., Politt D., Frank R.D., Westenfeld R., Ittel T.H., Floege J. Lumbar bone mineral density in very long-term renal transplant recipients: Impact of circulating sex hormones // Osteoporos Int. 2005;16(12):1611-20.
5. Cueto-Manzano A.M., Freemont A.J., Adams J.E., Mawer B., Gokal R., Hutchison A.J. Association of sex hormone status with the bone loss of renal transplant patients // Nephrol Dial Transplant. 2001;16(6): 1245-50.
6. Fassbender W.J., Balli M., Gortz B., Hinrichs B., Kaiser H.E., Tracke H.S. Sex steroids, biochemical markers, bone mineral density and histomorphometry in male osteoporosis patients // In Vivo. 2000;14(5): 611-8.
7. Hampson G., Bhargava N., Cheung J., Vaja S., Seed P.T., Fogelman I. Low circulating estradiol and adrenal androgens concentrations in men on glucocorticoids: a potential contributory factor in steroid-induced osteoporosis // Metabolism. 2002; 51(11):1458-62.
8. Hofle G., Tautermann G., Saely C.H., Drexel H. Sex-hormonebinding globulin is negatively correlated with femoral bone-mineral density in male cardiac-transplant recipients. // Wien Klin Wochenschr. 2004;116(5-6):170-5.
9. Kantarci G., Sahin S., Uras A.R., Ergin H. Effects of different calcineurin inhibitors on sex hormone levels in transplanted male patients // Transplant Proc. 2004;36(1):178-9.
10. Kokado Y., Takahara S., Ichimaru N., Toki K., Kyo M.,Permpongkosol S., Kojima Y., Inoue T., Wang J.D., Okuyama A. Factors influencing vertebral bone density after renal transplantation // Transpl Int. 2000;13 Suppl 1:S431-5.
11. Lormeau C., Soudan B., d'Herbomez M., Pigny P., Duquesnoy B., Cortet B. Sex hormone-binding globulin, estradiol, and bone turnover markers in male osteoporosis. // Bone. 2004;34(6):933-9.
12. Malyszko J., Malyszko J.S., Wolczynski S., Mysliwiec M. Osteoprotegerin and its correlations with new markers of bone formation and bone resorption in kidney transplant recipients // Transplant Proc. 2003; 35(6):2227-9.
13. Riggs B.L., Khosla S., Melton L.J. 3rd. Sex steroids and the construction and conservation of the adult skeleton // Endocr Rev. 2002;23(3):279-302. Review.
14. Roe S.D., Porter C.J., Godber I.M., Hosking D.J., Cassidy M.J. Reduced bone mineral density in male renal transplant recipients: evidence for persisting hyperparathyroidism // Osteoporos Int. 2005;16(2):142-8.
15. Tauchmanova L., Carrano R., Sabbatini M., De Rosa M., Orio F., Palomba S., Cascella T., Lombardi G., Federico S., Colao A. Hypothalamic-pituitary-gonadal axis function after successful kidney transplantation in men and women // Hum Reprod. 2004;19(4):867-73.
16. Tondolo V., Citterio F., Panocchia N., Nanni G., Favi E., Brescia A., Castagneto M. Gonadal function and immunosuppressive therapy after renal transplantation // Transplant Proc. 2005;37(4):1915-7.
Review
For citations:
PRONChENKO I.A., BUZULINA V.P., TOMILINA N.A., N VEDERNIKOVA R., ERMAKOVA I.P. ROL' POLOVYKh GORMONOV V REGULYaTsII KOSTNOGO OBMENA i mineral'noy plotnostikostnoy tkani u muzhchin v pozdnie sroki posle allotransplantatsii trupnoy pochki. Osteoporosis and Bone Diseases. 2006;9(2):2-5. (In Russ.) https://doi.org/10.14341/osteo200622-5
Views:
488
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
